QLT Inc: Premium Company Profile

Questions: Discounts, Updates etc.

Price: $495.00

Publication Date: 2008-01-14

Order Online Now

People that purchased this report also purchased:

Contact LeadDiscovery

  • If you have questions about this report
  • To find out if you qualify for a discount
  • Want a more up to date version
  • Can't find a report that meets your needs
Search all reports

Keywords:

Boolean terms AND, OR, NOT can be used. Phrases should be entered within quotes. For wildcards use an *

QLT was originally focused on discovering, developing and commercializing innovative therapies in the fields of ophthalmology and dermatology. In 2006, the company changed its focus to purely research and development by selling its manufacturing facility to Tolmar Pharmaceuticals.


Scope

  • Contains corporate strategy, value chain presence and SWOT Analysis
  • Provides detailed business description, segment analysis, 5-year financial trends, key products and key competitors
  • Includes information on suppliers/ partners, shareholding structure and key employees with biographies


    • Report Highlights
    QLT has two marketed products: Visudyne for the treatment of wet age-related macular degeneration (AMD), pathologic myopia and presumed ocular histoplasmosis and Eligard for the palliative treatment of advanced prostate cancer.

    QLT derives its revenues form of product sales (net product revenue and royalties), contract research and development, and licensing and milestones. The company enters into commercial license agreements with pharmaceutical and biotechnology companies to market its products.

    The company's total revenues increased at a CAGR of 11.9% during 2002-2006, from $110.5 million to $175.1 million. This represents an absolute total growth of +$64.6 million for total revenues. The company's biggest contributor to revenue growth during 2002-2006 was product sales of Visudyne and Eligard.


    Reasons to Purchase

  • Access all the important information and analysis on the company in a single report
  • Understand company's strengths, weaknesses, opportunities and threats along with business strategy and value chain
  • Gain access to company's adjusted five year financial data along with key ratios and market capitalization

    • Table of Contents

    Other users found this report page using the following search terms: QLT qlt eligard risperidone wattier analysis atrigel swot daniel inc competitors

    If you can't find a report that meets your needs contact LeadDiscovery. We are one of the few report providers with extensive drug development experience and we frequently use this knowledge to help clients source the most appropriate reports or produce reports for them from scratch.


    Refund and Cancellation Policy: The descriptions of the products and services sold on LeadDiscovery.co.uk are as complete and accurate as possible, and customers are encouraged to read all available information about a product before placing an order. Due to the nature of the information being sold, orders for reports cannot be canceled.